Approved
consistent with previous terms of clearance: This ICR is approved
on the understanding that results of these surveys will be
primarily for internal agency use only. The following terms of
clearance also apply. (1) To the extent that results will be made
public, all study limitations will need to be clearly discussed in
supporting statements and in public reports. Since NIH does not
plan for robust follow-up to minimize non-response, NIH should
report the response rates and analyze for potential non-response
bias. (2) This generic ICR is approved for the purpose of
conducting customer satisfaction surveys of similar scope to the
prototype ICs submitted as part of this package. (3) Given that
this generic ICR is not intended to be a robust evaluation of
program quality but, rather, informal customer satisfaction
surveys, NIH shall consider whether it really needs to survey over
58,000 respondents. Prior to submission of individual generic ICs
under this umbrella ICR, NIH will conduct a power analysis for each
generic IC and describe in the supporting statement how the target
sample sizes were determined and why they need to be so large for
purposes of a customer satisfaction survey. (4) When providing
assurances of confidentiality, NIH will disclose on all materials
sent to respondents the statutory authority NIH has to provide
assurances of confidentiality. If NIH determines it does not have
this statutory authority and has not obtained an equivalent
authority (e.g. certificate of confidentiality), NIH will not
provide assurances of confidentiality. (5) NIH will adhere to OMB
standards regarding race/ethnicity questions on all IC instruments.
(6) This generic ICR is approved consistent with NIH agreement to
submit individual collections to OMB as they are implemented, along
with all necessary supporting statements (to include information
about research design and analysis, incentives, burden estimates,
approaches to address non-response bias, etc). OMB will aim to
review each IC submission within 14 days; however, OMB approval
should not be assumed if not explicitly granted, even if 14 days
have elapsed since submission.
Inventory as of this Action
Requested
Previously Approved
12/31/2013
36 Months From Approved
12/31/2010
44,935
0
58,335
17,352
0
21,884
0
0
0
The Warren Grant Magnuson Clinical
Center will conduct surveys of its customers and other partners to
assess perceptions about the quality of care and services provided
at the Clinical Center. Data will be used to drive performance
improvement.
EO: EO
12862 Name/Subject of EO: Customer Satisfaction Surveys
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.